Loading insider details...
Latest Form 4 (Jul 6, 2026): Grant/Award of 152,207 ABCL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 6, 2026 | AbCellera Biologics Inc. (ABCL) | Grant/Award | 152,207 | n/a |
| Jun 25, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 6,068 | n/a |
| Jun 10, 2026 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 38,000 | n/a |
| Jun 3, 2026 | ADC Therapeutics SA (ADCT) | Grant/Award | 45,000 | n/a |
| Dec 12, 2025 | Merus N.V. (MRUS) | Disposition to Issuer | 13,193 | n/a |
| Nov 7, 2025 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 121,285 | n/a |
| Jun 27, 2025 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 16,000 | n/a |
| Jun 17, 2025 | ADC Therapeutics SA (ADCT) | Tax Withholding | 12,600 | $45.1K |
| Jun 13, 2025 | Prelude Therapeutics Inc (PRLD) | Grant/Award | 38,000 | n/a |
| Jun 5, 2025 | ADC Therapeutics SA (ADCT) | Grant/Award | 40,000 | n/a |